Introducing SKINSOO: an Interview with GIVET's CCO

An interview with Martin Placek, Chief Commercial Officer

SKINSOO is GIVET’s new Korean dermocosmetics brand built on exosome technology and clinically proven efficacy. It marks GIVET’s expansion into a fast-growing category with a science-first promise designed for European consumers.  

Introduction and Strategic Context

Q: GIVET has built a diverse portfolio in recent years. Why launch SKINSOO now, and why focus on Korean dermocosmetics? 

Martin Placek: We saw clear opportunity in dermocosmetics. The category in Europe is crowded with French and German incumbents, yet consumers are actively seeking lighter textures, smarter delivery systems, and results that last. SKINSOO brings a fresh answer by merging the rigor of dermo with the innovation cadence of Korean skincare, powered by exosome technology and validated by clinical testing.  

Q: How does SKINSOO fit into GIVET’s long-term strategy as a house of brands? 

Martin: As a B2B house of brands, we scale where consumer demand meets our operational strengths. We know Korean beauty well through our supplier network and brand experience, and we build brands with an asset-light model that lets us move fast without compromising quality. SKINSOO extends our portfolio into science-led dermo while using the same agile operating system that powers all GIVET launches.

Q: K-beauty has influenced global routines for years. How will SKINSOO stand out in Europe? 

Martin: Focus and clarity. SKINSOO is clean, minimalist, and fragrance-free by intent, built for high tolerance and visible results. It takes the essence of K-beauty rituals and translates them into efficient dermo routines designed for everyday European use. 

 

Brand Positioning and Unique Value

Q: What differentiates SKINSOO from other Korean or dermocosmetic brands? 

Martin: Three pillars. First, exosome-powered formulas that help active ingredients reach where they work best. Second, clinical credibility across the range. Third, a routine architecture that is simple to adopt and easy to stick with. Exosome delivery gives us precision, the clinical layer gives confidence, and the routine design keeps it practical.  

Q: Which consumer needs or gaps does SKINSOO address? 

Martin: People want healthy skin without heavy routines. They want lighter textures, smart layering, and actives that matter. SKINSOO focuses on barrier health, hydration, brightening, and tone evenness with high-tolerance formulas. It reflects how consumers actually care for skin today while raising the efficacy bar.  

Q: How important is scientific credibility, and how have you built it in?

Martin: It is core to the brand. SKINSOO is dermatologically tested, clinically proven efficacy, and built on patented Korean technologies like stabilized, plant-based exosomes and advanced carriers such as liposomes. Science sits at the center, not as a claim but as a system across development and validation.  

Building the Brand 

Q: What guided SKINSOO’s brand identity from positioning to product philosophy? 

Martin: The line had to read as true dermo and feel like modern K-beauty. That means clean design, fragrance-free formulas, and routines that guide you step by step. The look is clean and clinical. The experience is light yet effective.  

Q: How did GIVET’s market insight and agile setup shape SKINSOO?

 Martin: We combine in-house brand building with a network of top-tier suppliers and a proven go-to-market engine. Our teams collaborate across product, regulatory, operations, and marketing with clear decision gates, which is how we compress time from concept to shelf while keeping standards high.  

Q: What role does Korean skincare technology play in the formulas? 

Martin: It is foundational. Exosomes are nano-sized messengers that support the skin’s repair mechanisms and improve delivery of key actives. In SKINSOO they are the backbone of lines like HydraCell and LuminaCell, pairing exosomes with hyaluronic acid complexes, ceramides, peptides, niacinamide, and stabilized vitamin C for visible, durable outcomes.  

GIVET’s Vision for SKINSOO 

Q: Where do you want SKINSOO to be in two to three years, and what role will it play in the portfolio? 

Martin: Our goal is to scale thoughtfully. We will grow routines, introduce complementary lines, and expand the product matrix where consumers see the most value. Within skincare, SKINSOO will anchor our science-first dermo pillar, sitting alongside Saffee and KORIKA so we cover distinct consumer needs and price points. 

Q: How does launching SKINSOO strengthen GIVET’s broader mission? 

Martin: It shows our model at work. We identify an opportunity, design a brand around a clear consumer promise, leverage our supplier ecosystem, and support sell-out with in-house marketing. That is how we bring high-quality solutions to European markets at speed.  

Q: Will SKINSOO expand beyond skincare? 

Martin: No. SKINSOO stays dedicated to dermocosmetics. Our house-of-brands architecture lets each brand serve its category with focus, so other segments remain with the brands built for them.  

Final Reflection

Q: What does the SKINSOO launch mean to you as a leader at GIVET? 

Martin: It confirms that we can build end-to-end. From insight to identity, from formula to shelf, SKINSOO proves how our teams and partners deliver when a clear consumer need meets strong technology. 

Q: What is the one thing you want partners and retailers to remember about SKINSOO? 

Martin: Korean dermocosmetics with science-backed results. That is the promise.  

 

 

About SKINSOO 

Tagline: Exosome powered. Clinically proven. For results that last. 
Essence: Korean dermocosmetics with science backed results. 

About GIVET 

GIVET is an Italian B2B house of brands that builds, scales, and elevates beauty across categories through insight-driven innovation, operational agility, and full-spectrum partner support. Our asset-light model and supplier network enable speed with quality in 27 European markets.